Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.80
0.00 (0.00%)
Feb 11, 2026, 1:30 PM CST

TPEX:4111 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,3611,1651,0611,1431,022979.36
Revenue Growth (YoY)
23.28%9.86%-7.19%11.81%4.38%-4.26%
Cost of Revenue
830.63768.25717.76720.57665.72656.44
Gross Profit
530.33397.18343.1422.51356.58322.92
Selling, General & Admin
320.35280.24260.22248.99218.59229.15
Research & Development
16.751821.6719.6918.9418.21
Operating Expenses
337.1298.25281.89268.67237.52247.37
Operating Income
193.2398.9361.21153.84119.0675.55
Interest Expense
-0.62-1.74-1.46-1.53-1.09-0.16
Interest & Investment Income
8.7414.5816.6430.61.99
Currency Exchange Gain (Loss)
-4.3817.08-0.434.72-1.76-3.25
Other Non Operating Income (Expenses)
11.6811.2211.57.218.067.09
EBT Excluding Unusual Items
208.65140.0887.46167.24124.8681.22
Gain (Loss) on Sale of Investments
----5.03--
Gain (Loss) on Sale of Assets
-1.17-2.38-0.130.070.120.2
Asset Writedown
----6.8-
Other Unusual Items
--0---
Pretax Income
207.48137.787.33162.28131.7881.43
Income Tax Expense
42.1327.0718.66-1724.0822.28
Earnings From Continuing Operations
165.35110.6368.67179.28107.759.14
Earnings From Discontinued Operations
----25.28-26.95-
Net Income
165.35110.6368.67154.0180.7559.14
Net Income to Common
165.35110.6368.67154.0180.7559.14
Net Income Growth
131.35%61.10%-55.41%90.72%36.54%-18.37%
Shares Outstanding (Basic)
606060606060
Shares Outstanding (Diluted)
606060606060
Shares Change (YoY)
0.47%0.12%-0.16%0.06%0.10%-0.01%
EPS (Basic)
2.761.851.152.571.350.99
EPS (Diluted)
2.751.841.142.561.340.98
EPS Growth
131.97%60.83%-55.37%90.77%36.85%-18.89%
Free Cash Flow
148.26129.01-26.98109.53-125.53121.53
Free Cash Flow Per Share
2.462.15-0.451.82-2.092.02
Dividend Per Share
0.9520.9520.9521.1430.9520.952
Dividend Growth
---16.67%20.00%--
Gross Margin
38.97%34.08%32.34%36.96%34.88%32.97%
Operating Margin
14.20%8.49%5.77%13.46%11.65%7.71%
Profit Margin
12.15%9.49%6.47%13.47%7.90%6.04%
Free Cash Flow Margin
10.89%11.07%-2.54%9.58%-12.28%12.41%
EBITDA
259.12165.23123.17219.2190.95152.45
EBITDA Margin
19.04%14.18%11.61%19.18%18.68%15.57%
D&A For EBITDA
65.8966.361.9665.3671.976.9
EBIT
193.2398.9361.21153.84119.0675.55
EBIT Margin
14.20%8.49%5.77%13.46%11.65%7.71%
Effective Tax Rate
20.31%19.66%21.36%-18.27%27.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.